ID   CYH3_HUMAN              Reviewed;         400 AA.
AC   O43739; A4D2N8;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2001, sequence version 2.
DT   07-APR-2021, entry version 183.
DE   RecName: Full=Cytohesin-3;
DE   AltName: Full=ARF nucleotide-binding site opener 3;
DE            Short=Protein ARNO3;
DE   AltName: Full=General receptor of phosphoinositides 1;
DE            Short=Grp1;
DE   AltName: Full=PH, SEC7 and coiled-coil domain-containing protein 3;
GN   Name=CYTH3 {ECO:0000312|HGNC:HGNC:9504}; Synonyms=ARNO3, GRP1, PSCD3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), LIPID-BINDING, DOMAIN, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=9742223; DOI=10.1042/bj3350139;
RA   Venkateswarlu K., Gunn-Moore F., Oatey P.B., Tavare J.M., Cullen P.J.;
RT   "Nerve growth factor- and epidermal growth factor-stimulated translocation
RT   of the ADP-ribosylation factor-exchange factor GRP1 to the plasma membrane
RT   of PC12 cells requires activation of phosphatidylinositol 3-kinase and the
RT   GRP1 pleckstrin homology domain.";
RL   Biochem. J. 335:139-146(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND FUNCTION.
RC   TISSUE=Placenta;
RX   PubMed=9707577; DOI=10.1073/pnas.95.17.9926;
RA   Franco M., Boretto J., Robineau S., Monier S., Goud B., Chardin P.,
RA   Chavrier P.;
RT   "ARNO3, a Sec7-domain guanine nucleotide exchange factor for ADP
RT   ribosylation factor 1, is involved in the control of Golgi structure and
RT   function.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:9926-9931(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   ALTERNATIVE SPLICING.
RX   PubMed=10652308; DOI=10.1074/jbc.275.5.3221;
RA   Ogasawara M., Kim S.C., Adamik R., Togawa A., Ferrans V.J., Takeda K.,
RA   Kirby M., Moss J., Vaughan M.;
RT   "Similarities in function and gene structure of cytohesin-4 and cytohesin-
RT   1, guanine nucleotide-exchange proteins for ADP-ribosylation factors.";
RL   J. Biol. Chem. 275:3221-3230(2000).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17398095; DOI=10.1016/j.cub.2007.03.007;
RA   Hofmann I., Thompson A., Sanderson C.M., Munro S.;
RT   "The Arl4 family of small G proteins can recruit the cytohesin Arf6
RT   exchange factors to the plasma membrane.";
RL   Curr. Biol. 17:711-716(2007).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 247-400 IN COMPLEX WITH
RP   PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE AND ARF6, FUNCTION, DOMAIN,
RP   LIPID-BINDING, MUTAGENESIS OF 398-ASN--LYS-400, AUTOINHIBITORY REGION, AND
RP   INTERACTION WITH ARF6.
RX   PubMed=23940353; DOI=10.1073/pnas.1301883110;
RA   Malaby A.W., van den Berg B., Lambright D.G.;
RT   "Structural basis for membrane recruitment and allosteric activation of
RT   cytohesin family Arf GTPase exchange factors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:14213-14218(2013).
CC   -!- FUNCTION: Promotes guanine-nucleotide exchange on ARF1 and ARF6.
CC       Promotes the activation of ARF factors through replacement of GDP with
CC       GTP. Plays a role in the epithelial polarization (By similarity).
CC       {ECO:0000250|UniProtKB:O08967, ECO:0000269|PubMed:23940353,
CC       ECO:0000269|PubMed:9707577}.
CC   -!- SUBUNIT: Interacts with TAMALIN (By similarity). Interacts with ARF6
CC       (PubMed:23940353). Interacts with FRMD4A (By similarity). Interacts
CC       with FRMD4B (By similarity). {ECO:0000250|UniProtKB:O08967,
CC       ECO:0000269|PubMed:23940353}.
CC   -!- INTERACTION:
CC       O43739; Q96HB5-4: CCDC120; NbExp=3; IntAct=EBI-741648, EBI-10185348;
CC       O43739; Q969H4: CNKSR1; NbExp=4; IntAct=EBI-741648, EBI-741671;
CC       O43739; Q8N0S2: SYCE1; NbExp=3; IntAct=EBI-741648, EBI-6872807;
CC       O43739-2; P53365: ARFIP2; NbExp=3; IntAct=EBI-11974015, EBI-638194;
CC       O43739-2; Q96HB5: CCDC120; NbExp=4; IntAct=EBI-11974015, EBI-744556;
CC       O43739-2; Q969H4: CNKSR1; NbExp=4; IntAct=EBI-11974015, EBI-741671;
CC       O43739-2; P80217-2: IFI35; NbExp=3; IntAct=EBI-11974015, EBI-12823003;
CC       O43739-2; Q8WWN9: IPCEF1; NbExp=3; IntAct=EBI-11974015, EBI-4401965;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol. Cell membrane
CC       {ECO:0000250|UniProtKB:O08967}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:O08967}. Cell junction, adherens junction
CC       {ECO:0000250|UniProtKB:O08967}. Cell junction, tight junction
CC       {ECO:0000250|UniProtKB:O08967}. Note=Translocates from the cytosol to
CC       membranes enriched in phosphatidylinositol 3,4,5-trisphosphate.
CC       {ECO:0000250|UniProtKB:O08967}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O43739-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O43739-2; Sequence=VSP_006039;
CC   -!- TISSUE SPECIFICITY: Almost absent from liver, thymus and peripheral
CC       blood lymphocytes.
CC   -!- DOMAIN: Binds via its PH domain to the inositol head group of
CC       phosphatidylinositol 3,4,5-trisphosphate.
CC   -!- DOMAIN: Autoinhibited by its C-terminal basic region.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ005197; CAA06434.1; -; mRNA.
DR   EMBL; AJ223957; CAA11686.1; -; mRNA.
DR   EMBL; CH236963; EAL23717.1; -; Genomic_DNA.
DR   EMBL; CH878731; EAW55046.1; -; Genomic_DNA.
DR   EMBL; BC028717; AAH28717.1; -; mRNA.
DR   CCDS; CCDS5346.1; -. [O43739-2]
DR   RefSeq; NP_004218.1; NM_004227.3. [O43739-2]
DR   PDB; 4KAX; X-ray; 1.85 A; B=247-400.
DR   PDB; 6U3E; EM; 53.00 A; A/B=13-400.
DR   PDB; 6U3G; EM; 53.00 A; A/B=13-400.
DR   PDBsum; 4KAX; -.
DR   PDBsum; 6U3E; -.
DR   PDBsum; 6U3G; -.
DR   BMRB; O43739; -.
DR   SMR; O43739; -.
DR   BioGRID; 114686; 22.
DR   CORUM; O43739; -.
DR   DIP; DIP-60444N; -.
DR   IntAct; O43739; 14.
DR   STRING; 9606.ENSP00000297044; -.
DR   BindingDB; O43739; -.
DR   ChEMBL; CHEMBL3259466; -.
DR   DrugBank; DB01863; Inositol 1,3,4,5-Tetrakisphosphate.
DR   DrugBank; DB03344; Inositol-(1,3,4,5,6)-Pentakisphosphate.
DR   iPTMnet; O43739; -.
DR   PhosphoSitePlus; O43739; -.
DR   BioMuta; CYTH3; -.
DR   EPD; O43739; -.
DR   jPOST; O43739; -.
DR   MassIVE; O43739; -.
DR   MaxQB; O43739; -.
DR   PaxDb; O43739; -.
DR   PeptideAtlas; O43739; -.
DR   PRIDE; O43739; -.
DR   ProteomicsDB; 49142; -. [O43739-1]
DR   ProteomicsDB; 49143; -. [O43739-2]
DR   Antibodypedia; 2818; 197 antibodies.
DR   DNASU; 9265; -.
DR   Ensembl; ENST00000350796; ENSP00000297044; ENSG00000008256. [O43739-2]
DR   Ensembl; ENST00000396741; ENSP00000379967; ENSG00000008256. [O43739-1]
DR   GeneID; 9265; -.
DR   KEGG; hsa:9265; -.
DR   UCSC; uc003spt.4; human. [O43739-1]
DR   CTD; 9265; -.
DR   DisGeNET; 9265; -.
DR   GeneCards; CYTH3; -.
DR   HGNC; HGNC:9504; CYTH3.
DR   HPA; ENSG00000008256; Tissue enhanced (placenta).
DR   MIM; 605081; gene.
DR   neXtProt; NX_O43739; -.
DR   OpenTargets; ENSG00000008256; -.
DR   PharmGKB; PA164718590; -.
DR   VEuPathDB; HostDB:ENSG00000008256.15; -.
DR   eggNOG; KOG0930; Eukaryota.
DR   GeneTree; ENSGT00940000155825; -.
DR   HOGENOM; CLU_032820_3_0_1; -.
DR   InParanoid; O43739; -.
DR   OMA; CEIAEVM; -.
DR   OrthoDB; 657055at2759; -.
DR   PhylomeDB; O43739; -.
DR   TreeFam; TF352091; -.
DR   PathwayCommons; O43739; -.
DR   Reactome; R-HSA-6811438; Intra-Golgi traffic.
DR   BioGRID-ORCS; 9265; 9 hits in 995 CRISPR screens.
DR   ChiTaRS; CYTH3; human.
DR   GeneWiki; CYTH3; -.
DR   GenomeRNAi; 9265; -.
DR   Pharos; O43739; Tbio.
DR   PRO; PR:O43739; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; O43739; protein.
DR   Bgee; ENSG00000008256; Expressed in metanephros and 222 other tissues.
DR   Genevisible; O43739; HS.
DR   GO; GO:0005912; C:adherens junction; ISS:UniProtKB.
DR   GO; GO:0005923; C:bicellular tight junction; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0001726; C:ruffle; IEA:Ensembl.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:UniProtKB.
DR   GO; GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB.
DR   GO; GO:0090162; P:establishment of epithelial cell polarity; ISS:UniProtKB.
DR   GO; GO:0048193; P:Golgi vesicle transport; IMP:UniProtKB.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; IEA:Ensembl.
DR   GO; GO:0032012; P:regulation of ARF protein signal transduction; IEA:InterPro.
DR   CDD; cd00171; Sec7; 1.
DR   Gene3D; 1.10.1000.11; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR023394; Sec7_C_sf.
DR   InterPro; IPR000904; Sec7_dom.
DR   InterPro; IPR035999; Sec7_dom_sf.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF01369; Sec7; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00222; Sec7; 1.
DR   SUPFAM; SSF48425; SSF48425; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50190; SEC7; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Coiled coil; Cytoplasm; Guanine-nucleotide releasing factor; Lipid-binding;
KW   Membrane; Reference proteome; Tight junction.
FT   CHAIN           1..400
FT                   /note="Cytohesin-3"
FT                   /id="PRO_0000120200"
FT   DOMAIN          77..206
FT                   /note="SEC7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00189"
FT   DOMAIN          264..381
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   REGION          273..281
FT                   /note="Phosphatidylinositol 3,4,5-trisphosphate binding"
FT   REGION          392..400
FT                   /note="C-terminal autoinhibitory region"
FT                   /evidence="ECO:0000269|PubMed:23940353"
FT   COILED          14..61
FT                   /evidence="ECO:0000255"
FT   BINDING         285
FT                   /note="Phosphatidylinositol 3,4,5-trisphosphate"
FT                   /evidence="ECO:0000269|PubMed:23940353"
FT   BINDING         296
FT                   /note="Phosphatidylinositol 3,4,5-trisphosphate"
FT                   /evidence="ECO:0000269|PubMed:23940353"
FT   BINDING         306
FT                   /note="Phosphatidylinositol 3,4,5-trisphosphate"
FT                   /evidence="ECO:0000269|PubMed:23940353"
FT   BINDING         355
FT                   /note="Phosphatidylinositol 3,4,5-trisphosphate"
FT                   /evidence="ECO:0000269|PubMed:23940353"
FT   VAR_SEQ         277
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9707577, ECO:0000303|PubMed:9742223"
FT                   /id="VSP_006039"
FT   MUTAGEN         398..400
FT                   /note="NKK->AAA: Abolishes autoinhibition and increases
FT                   guanine-nucleotide exchange activity."
FT                   /evidence="ECO:0000269|PubMed:23940353"
FT   HELIX           259..262
FT                   /evidence="ECO:0007744|PDB:4KAX"
FT   STRAND          266..274
FT                   /evidence="ECO:0007744|PDB:4KAX"
FT   STRAND          282..290
FT                   /evidence="ECO:0007744|PDB:4KAX"
FT   STRAND          293..299
FT                   /evidence="ECO:0007744|PDB:4KAX"
FT   STRAND          306..310
FT                   /evidence="ECO:0007744|PDB:4KAX"
FT   STRAND          315..319
FT                   /evidence="ECO:0007744|PDB:4KAX"
FT   STRAND          322..331
FT                   /evidence="ECO:0007744|PDB:4KAX"
FT   STRAND          333..335
FT                   /evidence="ECO:0007744|PDB:4KAX"
FT   STRAND          343..345
FT                   /evidence="ECO:0007744|PDB:4KAX"
FT   STRAND          351..353
FT                   /evidence="ECO:0007744|PDB:4KAX"
FT   STRAND          359..362
FT                   /evidence="ECO:0007744|PDB:4KAX"
FT   HELIX           366..379
FT                   /evidence="ECO:0007744|PDB:4KAX"
FT   HELIX           384..396
FT                   /evidence="ECO:0007744|PDB:4KAX"
SQ   SEQUENCE   400 AA;  46349 MW;  87FB917899EE957D CRC64;
     MDEDGGGEGG GVPEDLSLEE REELLDIRRR KKELIDDIER LKYEIAEVMT EIDNLTSVEE
     SKTTQRNKQI AMGRKKFNMD PKKGIQFLIE NDLLQSSPED VAQFLYKGEG LNKTVIGDYL
     GERDEFNIKV LQAFVELHEF ADLNLVQALR QFLWSFRLPG EAQKIDRMME AFASRYCLCN
     PGVFQSTDTC YVLSFAIIML NTSLHNHNVR DKPTAERFIA MNRGINEGGD LPEELLRNLY
     ESIKNEPFKI PEDDGNDLTH TFFNPDREGW LLKLGGGRVK TWKRRWFILT DNCLYYFEYT
     TDKEPRGIIP LENLSIREVE DPRKPNCFEL YNPSHKGQVI KACKTEADGR VVEGNHVVYR
     ISAPSPEEKE EWMKSIKASI SRDPFYDMLA TRKRRIANKK
//
